Last Edited: 2 months ago
Maria Palombini1
Posted on: 25/08/2026
sorted by publishing date
Last Edited: 8 months ago
In 2025, the European Union Drugs Agency (EUDA) completed the project Synthetic Drugs 2050 to address increasing uncertainty surrounding the future production, distribution, and use of synthetic drugs in Europe up to 2050. Using horizon scanning, trend analysis, and sense-making approaches, the Foresight on Demand (FOD) project team and EUDA jointly developed four plausible scenarios to support EU-level and national stakeholders in anticipating emerging risks, identifying opportunities, and reinforcing the resilience of future policies.
The 2026 FOD–EUDA project marks the second phase of this foresight work and will focus on:
The project will deliver:
Posted on: 18/02/2026
Last Edited: 8 months ago
The European Union Drugs Agency’s (EUDA) project “Synthetic Drugs 2050” addressed the growing uncertainty surrounding the future availability, spread, and use of synthetic drugs in Europe up to 2050. Synthetic drugs represent a rapidly evolving and systemic challenge for Europe, affecting public health, security, social cohesion, productivity, and overall wellbeing. Accelerated technological change, globalised supply chains, digitalisation, and increasingly blurred boundaries between legal, illegal, controlled, and uncontrolled substances further amplify the complexity of this issue.
The project applied a participatory strategic foresight approach to explore possible futures of synthetic drugs in Europe, moving beyond short-term monitoring and reactive policy responses. By systematically analysing global and regional drivers of change, emerging trends, weak signals, and deep uncertainties, the project built a shared understanding of how synthetic drugs markets, uses, and impacts may evolve in the medium- and long-term.
Through horizon scanning, trend analysis, scenario building, and sense-making activities, Synthetic Drugs 2050 supports EU-level and national stakeholders in anticipating risks, identifying opportunities, and strengthening policy resilience. The project explicitly linked foresight insights to strategic reflection, policy options, and research priorities, while embedding capacity-building components to enhance futures literacy and long-term preparedness within the EU drug policy ecosystem.
Objectives
The Synthetic Drugs 2050 project encompassed:
Outputs
Find more information here: https://www.euda.europa.eu/index_en
Posted on: 18/02/2026